Schizophrenia Although according to other studies it appears to have comparable efficacy to olanzapine in the treatment of schizophrenia.<unk>  augmentation, similarly to sulpiride augmentation, has been considered a viable treatment option (although this is based on low-quality evidence) in clozapine-resistant cases of schizophrenia. Another recent study concluded that<unk>  is an appropriate first-line treatment for the management of acute psychosis. Postoperative nausea and vomiting<unk>  is indicated for use in the United States in adults for the prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class; and to treat PONV in those who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.
Amisulpride
Icatibant
Deutetrabenazine
Suvorexant
Adatanserin
Bedaquiline
Daridorexant
Pirlindole